| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
2 － ? |
Cefoxitin (Mefoxin)  |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
2 － ? |
Ceftizoxime (Cefizox) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
2 － ? |
Cephradine (Cefradine, Velocef) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
2 － ? |
Chloramphenicol (Chloromycetin) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
2 － ? |
Kanamycin (Kantrex) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
4 － ? |
Cefotetan (Cefotan) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
4 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
8 － ? |
Cefixime (Suprax) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
8 － ? |
Fosfomycin (Phosphonomycin, Phosphomycin, Monurol) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
8 － ? |
Nitrofurantoin (Macrobid, Macrodantin, Furantoin) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
>128 － ? |
Aztreonam (Azactam) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
>128 － ? |
Nalidixic acid (NegGam) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
128 － ? |
Polymyxin E (Colistin) |
401 |
| Staphylococcus aureus (ATCC 6571) |
- |
- |
250 － ? |
Pefloxacin |
401 |
| Staphylococcus aureus (ATCC 700698 + methicillin-resistant) |
- |
- |
0.063 － ? |
Triclosan |
186 |
| Staphylococcus aureus (ATCC 700698 + methicillin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
186 |
| Staphylococcus aureus (ATCC 700698 + methicillin-resistant) |
- |
- |
4 － ? |
NB2001 |
186 |
| Staphylococcus aureus (ATCC 700698 + methicillin-resistant) |
- |
- |
>32 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |
| Staphylococcus aureus (ATCC 700699 + methicillin-resistant + quinolone-resistant + vanco) |
- |
- |
2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
336 |
| Staphylococcus aureus (ATCC 700699) |
- |
- |
0.125 － ? |
ACH-702 |
1279 |
| Staphylococcus aureus (ATCC 700699) |
- |
- |
4 － ? |
Gemifloxacin |
1279 |
| Staphylococcus aureus (ATCC 700699) |
- |
- |
4 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1279 |
| Staphylococcus aureus (ATCC 700699) |
- |
- |
64 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1279 |
| Staphylococcus aureus (ATCC 700699) |
- |
- |
>64 － ? |
Ethidium bromide (EtBr) |
1279 |
| Staphylococcus aureus (ATCC 700787 + methicillin-resistant) |
- |
- |
≤0.016 － ? |
NB2001 |
186 |
| Staphylococcus aureus (ATCC 700787 + methicillin-resistant) |
- |
- |
≤0.016 － ? |
Triclosan |
186 |
| Staphylococcus aureus (ATCC 700787 + methicillin-resistant) |
- |
- |
8 － ? |
Vancomycin (Vancocyn, Lyphocin) |
186 |
| Staphylococcus aureus (ATCC 700787 + methicillin-resistant) |
- |
- |
>32 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |